Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
This study evaluate the addition of metformin to standard of care in locally advanced and metastatic prostate cancer, half the patient will receive metformin in combination with standard treatment, and the other half will receive the standard of care only
Epistemonikos ID: d91d8fef2c200b9967d2c2c52a6fc4b2ad3e9c59
First added on: May 20, 2024